MHRA
MHRA grants Promising Innovative Medicine Designation to Sanofi’s RSV drug
January 19, 2021Manufacturing and Production MHRA, Sanofi
The MHRA has granted a Promising Innovative Medicine (PIM) Designation to Sanofi’s nirsevimab, which is being investigated a passive immunisation …
MHRA warns patients with history of significant allergic reactions not to receive Pfizer/BioNTech COVID-19 vaccine
December 9, 2020Research and Development COVID-19, MHRA, UK, Vaccine
While the rolling out of Pfizer and BioNTech’s COVID-19 in the UK this week marked a historic moment in a …
MHRA gives OK to Bavencio for first-line maintenance of advanced bladder cancer via the Early Access to Medicines Scheme
September 3, 2020Sales and Marketing Bavencio, MHRA, Merck, Pfizer, UK, eams, pharma
It has been revealed that Bavencio (avelumab), jointly developed by Merck KGaA and Pfizer, has been approved by the UK …
MHRA designates cenobamate as a Promising Innovative Medicine for treating drug resistant seizures
August 13, 2020Research and Development MHRA, cenobamate, seizures
Arvelle Therapeutics has announced that the UK’s Medicines and Healthcare Products Regulatory Agency (MHRA) has given their anti-seizure medication (cenobamate) …
MHRA launches new pharmacovigilance reporting platform for COVID-19 treatments
May 5, 2020Manufacturing and Production, Research and Development COVID-19, MHRA, UK, coronavirus, pharma
A new online reporting site has been launched by the Medicines and Healthcare products Regulatory Agency’s (MHRA) to track potential …
MHRA expands approval of Dysport for symptomatic treatment of focal spasticity of the upper limbs in paediatric cerebral palsy
January 6, 2020Sales and Marketing Dysport, MHRA, ipsen, pharma
Ipsen has secured an expansion in the UK to the existing label for Dysport (lemborexant), with the Medicines and Healthcare …
Over half of all US/EU regulator warnings issued to Indian and Chinese manufacturers, report finds
August 28, 2019Manufacturing and Production, Research and Development China, India, MHRA, UK, manufacturing, pharma
Concerns have been raised concerning the integrity of the global supply chain after a report from The Pharmaceutical Journal revealed …
Medicines recalled after FMD alert
July 1, 2019Sales and Marketing FMD, MHRA, labels, pharma, recall, supply chain
The MHRA has warned patients that batches of drugs for Parkinson’s, epilepsy and blood clots have been taken out of …
MHRA recall M&A Pharmachem’s paracetamol due to fungal contamination
June 18, 2019Manufacturing and Production Contamination, MHRA, fungal, paracetamol, pharma
The UK Medicines and Healthcare Products Regulatory Agency (MHRA) has issued a recall of M&A Pharmachem’s 500mg paracetamol tablets. The …
MHRA warns of congenital malformation risk of neo-mercazole during pregnancy
February 22, 2019Medical Communications, Research and Development MHRA, neo-mercazole, pharma
UK drug watchdog The Medicines and Healthcare products Regulatory Agency (MHRA) has warned of the potential side-effects of Neo-mercazole (carbimazole) …
MHRA issues recall of irbesartan blood pressure meds over carcinogen contamination concerns
January 4, 2019Manufacturing and Production, Medical Communications MHRA, irbesartan, pharma, sartan, valsartan
Following a number of recalls issued in the US and Europe in the latter half of 2018 for the blood …
MHRA Chief to step down in 2019
November 21, 2018Medical Communications, Research and Development MHRA, UK, brexit, pharma
The Medicines and Healthcare products Regulatory Agency (MHRA), the regulator responsible for the efficacy and safety of medicines in the …
MHRA to consult on potential for no-deal Brexit
October 5, 2018Medical Communications EU, MHRA, brexit, uk politics
The Medicines and Healthcare products Regulatory Agency (MHRA) has opened a consultation on how its legislation and regulatory processes would …
Drug safety: UK and EU post-Brexit
September 10, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EMA, EU, Europe, MHRA, UK, brexit, drug safety, pharmacovigilance
What does Brexit mean for drug safety in Europe and the United Kingdom? Louis Goss looks into Britain’s exit from …
Top Ten most popular articles on Pharmafile.com this week
September 7, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EMA, MHRA, Trump, brexit, research, scandal, top 10
Brexit took the top two spots this week after it was revealed that the EMA has awarded Britain’s MHRA just …
Latest content
FibroFind appoints Lee Borthwick as CEO
